Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation

British Journal of Haematology

Volumn 142, Issue 3, 2008, Pages 404-412

  Costa, Luciano J ^a   Feldman, Andrew L ^a   Micallef, Ivana N ^a   Inwards, David J ^a   Johnston, Patrick B ^a   Porrata, Luis F ^a   Ansell, Stephen M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diffuse large B cell lymphoma; Germinal centre; Immunohistochemistry; Salvage therapy; Stem cell transplantation

Indexed keywords

ACICLOVIR; BILIRUBIN; CARMUSTINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COTRIMOXAZOLE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 4; LEVOFLOXACIN; MELPHALAN; PENICILLIN G; PROTEIN BCL 2; PROTEIN BCL 6;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CANCER SURVIVOR; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; GERMINAL CENTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 46949111833     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07207.x     Document Type: Article

References (36)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503 511.
2. Baron, B.W., Nucifora, G., McCabe, N., Espinosa, R., 3rd, Le Beau, M.M. McKeithan, T.W. (1993) Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America, 90, 5262 5266.
3. Barrans, S.L., Carter, I., Owen, R.G., Davies, F.E., Patmore, R.D., Haynes, A.P., Morgan, G.J. Jack, A.S. (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood, 99, 1136 1143.
4. Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., Hagenbeek, A., Somers, R., Chauvin, F. Philip, T. (1998) The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group. Blood, 92, 3562 3568.
5. Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T.J., Thieblemont, C., Ferme, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H. Reyes, F. (2007) CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 25, 787 792.
6. Cabanillas, F., Hagemeister, F.B., McLaughlin, P., Velasquez, W.S., Riggs, S., Fuller, L. Smith, T. (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. Journal of Clinical Oncology, 5, 407 412.
7. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. Gisselbrecht, C. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 235 242.
8. Colomo, L., Lopez-Guillermo, A., Perales, M., Rives, S., Martinez, A., Bosch, F., Colomer, D., Falini, B., Montserrat, E. Campo, E. (2003) Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood, 101, 78 84.
9. Costa, L., Micallef, I., Inwards, D., Johnston, P., Porrata, L. Ansell, S. (2007) Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation. Blood, 110, 1897.
10. Dogan, A., Bagdi, E., Munson, P. Isaacson, P.G. (2000) CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. American Journal of Surgical Pathology, 24, 846 852.
11. Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali-Tanci, L., Ugolini, B., Sebastiani, C., Cattoretti, G., Pileri, S., Dalla-Favera, R. Stein, H. (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood, 95, 2084 2092.
12. Feugier, P., Van Hoof, A., Sebban, C., Solal-Celigny, P., Bouabdallah, R., Ferme, C., Christian, B., Lepage, E., Tilly, H., Morschhauser, F., Gaulard, P., Salles, G., Bosly, A., Gisselbrecht, C., Reyes, F. Coiffier, B. (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 23, 4117 4126.
13. Gascoyne, R.D., Adomat, S.A., Krajewski, S., Krajewska, M., Horsman, D.E., Tolcher, A.W., O'Reilly, S.E., Hoskins, P., Coldman, A.J., Reed, J.C. Connors, J.M. (1997) Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90, 244 251.
14. Gutierrez, M., Chabner, B.A., Pearson, D., Steinberg, S.M., Jaffe, E.S., Cheson, B.D., Fojo, A. Wilson, W.H. (2000) Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH. Journal of Clinical Oncology, 18, 3633 3642.
15. Habermann, T.M., Weller, E.A., Morrison, V.A., Gascoyne, R.D., Cassileth, P.A., Cohn, J.B., Dakhil, S.R., Woda, B., Fisher, R.I., Peterson, B.A. Horning, S.J. (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. Journal of Clinical Oncology, 24, 3121 3127.
16. Hamlin, P.A., Zelenetz, A.D., Kewalramani, T., Qin, J., Satagopan, J.M., Verbel, D., Noy, A., Portlock, C.S., Straus, D.J., Yahalom, J., Nimer, S.D. Moskowitz, C.H. (2003) Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood, 102, 1989 1996.
17. Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Muller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275 282.
18. van Imhoff, G.W., Boerma, E.J., van der Holt, B., Schuuring, E., Verdonck, L.F., Kluin-Nelemans, H.C. Kluin, P.M. (2006) Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. Journal of Clinical Oncology, 24, 4135 4142.
19. Jabbour, E., Peslin, N., Arnaud, P., Ferme, C., Carde, P., Vantelon, J., Bocaccio, C., Bourhis, J., Koscielny, S. Ribrag, V. (2005) Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation. Leukaemia & Lymphoma, 46, 861 867.
20. Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
21. Kerckaert, J.P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G. Bastard, C. (1993) LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nature Genetics, 5, 66 70.
22. Kramer, M.H., Hermans, J., Parker, J., Krol, A.D., Kluin-Nelemans, J.C., Haak, H.L., van Groningen, K., van Krieken, J.H., de Jong, D. Kluin, P.M. (1996) Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. Journal of Clinical Oncology, 14, 2131 2138.
23. Kurtin, P.J., Hobday, K.S., Ziesmer, S. Caron, B.L. (1999) Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. American Journal of Clinical Pathology, 112, 319 329.
24. Lossos, I.S., Jones, C.D., Warnke, R., Natkunam, Y., Kaizer, H., Zehnder, J.L., Tibshirani, R. Levy, R. (2001) Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood, 98, 945 951.
25. Moskowitz, C.H., Nimer, S.D., Glassman, J.R., Portlock, C.S., Yahalom, J., Straus, D.J., O'Brien, J.P., Elkin, N., Bertino, J.R. Zelenetz, A.D. (1999) The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma. Bone Marrow Transplantation, 23, 561 567.
26. Moskowitz, C.H., Zelenetz, A.D., Kewalramani, T., Hamlin, P., Lessac-Chenen, S., Houldsworth, J., Olshen, A., Chaganti, R., Nimer, S. Teruya-Feldstein, J. (2005) Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood, 106, 3383 3385.
27. Mounier, N., Briere, J., Gisselbrecht, C., Emile, J.F., Lederlin, P., Sebban, C., Berger, F., Bosly, A., Morel, P., Tilly, H., Bouabdallah, R., Reyes, F., Gaulard, P. Coiffier, B. (2003) Rituximab plus CHOP (R-CHOP) overcomes bcl-2 - associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood, 101, 4279 4284.
28. Muris, J.J., Meijer, C.J., Vos, W., van Krieken, J.H., Jiwa, N.M., Ossenkoppele, G.J. Oudejans, J.J. (2006) Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. Journal of Pathology, 208, 714 723.
29. Nyman, H., Adde, M., Karjalainen-Lindsberg, M.L., Taskinen, M., Berglund, M., Amini, R.M., Blomqvist, C., Enblad, G. Leppa, S. (2007) Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood, 109, 4930 4935.
30. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540 1545.
31. Remstein, E.D., Dogan, A., Einerson, R.R., Paternoster, S.F., Fink, S.R., Law, M., Dewald, G.W. Kurtin, P.J. (2006) The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. American Journal of Surgical Pathology, 30, 1546 1553.
32. Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Powell, J., Duffey, P.L., Longo, D.L., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E., Lopez-Guillermo, A., Grogan, T.M., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. Staudt, L.M. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 1937 1947.
33. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood, 89, 3909 3918.
34. Tsuboi, K., Iida, S., Inagaki, H., Kato, M., Hayami, Y., Hanamura, I., Miura, K., Harada, S., Kikuchi, M., Komatsu, H., Banno, S., Wakita, A., Nakamura, S., Eimoto, T. Ueda, R. (2000) MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia, 14, 449 456.
35. Velasquez, W.S., Cabanillas, F., Salvador, P., McLaughlin, P., Fridrik, M., Tucker, S., Jagannath, S., Hagemeister, F.B., Redman, J.R. Swan, F. (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood, 71, 117 122.
36. Zinzani, P.L., Dirnhofer, S., Sabattini, E., Alinari, L., Piccaluga, P.P., Stefoni, V., Tani, M., Musuraca, G., Marchi, E., Falini, B., Baccarani, M. Pileri, S.A. (2005) Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. Haematologica, 90, 341 347.